PRESCRIPTION DRUG MONITORING PROGRAM TRAINING AND TECHNICAL ASSISTANCE CENTER
The Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC) at the Institute for Intergovernmental Research (IIR) provides a comprehensive array of services, support, resources, & strategies to PDMPs, federal partners and other stakeholders to further the efforts and effectiveness of PDMPs in combating the misuse and diversion of prescription drugs.
News & Events
-
Harold Rogers Prescription Drug Monitoring Program Meeting Presentations Posted on PDMP TTAC Website
Read More September 10, 2026The presentation material from the 2026 Harold Rogers Prescription Drug Monitoring Program Meeting have been posted on the PDMP TTAC Website under Learning > Meetings and Convenings (Virtual: PDMP TTAC (opens in a new tab))
-
LAPPA publishes Model Addressing Inhalant Use Act
Read More August 25, 2026The Legislative Analysis and Public Policy Association (LAPPA) is excited to announce publication of the Model Addressing Inhalant Use Act (opens in a new tab). The purpose of this legislation is to: (1) prohibit the sale of certain products containing inhalants to minors; (2) establish additional requirements for the sale of inhalants, including restrictions on advertising and the retail sale of nitrous oxide as well as packaging requirements; (3) establish criminal penalties related to inhalants; and (4) establish education, prevention, and treatment requirements. Regulating inhalants is complicated because many inhalants are common household substances, but doing so is growing increasingly critical as this availability and appearance of “safety” results in adolescents being the largest demographic that uses inhalants. This Model Act seeks to: (1) to implement measures to educate the public, particularly adolescents, on the dangers of inhalant use; and (2) prevent initiation into inhalant use by placing restrictions on purchasing certain products.
-
DEA Recognizes National Fentanyl Prevention and Awareness Day
Read More August 19, 2026Washington – On Friday, August 21, 2026, the U.S. Drug Enforcement Administration will join Facing Fentanyl (opens in a new tab), to unite families, communities, and organizations across the country in recognizing National Fentanyl Prevention and Awareness Day. This year marks the fifth anniversary of the national observance which honors and remembers the lives lost to fentanyl poisoning.
This year’s theme, “Power of the Parent,” recognizes the critical role parents and families play in shaping conversations, raising awareness, and helping protect loved ones. Their voices make a meaningful impact: One Nation. One Fight. Facing Fentanyl. Together.
This day serves as a nationwide call to action to increase awareness to the highly addictive and dangerous drugs containing fentanyl that continue to drive the opioid epidemic and take lives. DEA’s observation of National Fentanyl Prevention and Awareness Day will include extended DEA Museum hours and the Faces of Fentanyl memorial exhibit from 6 a.m. to 6 p.m. on Friday, August 21.
"Every day that I walk into DEA Headquarters, I am reminded of the enormous toll of the fentanyl crisis. Thousands of faces make up DEA's Faces of Fentanyl memorial exhibit, and each month we receive hundreds of new photos,” said DEA Administrator Terrance Cole. “I've also met remarkable parents who have turned their grief into action – educating communities, advocating for change, and saving lives. Parents are our most powerful allies in this fight, and together, we will build a Fentanyl Free America."
The Faces of Fentanyl memorial exhibit is a representation of the faces of Americans – all ages, all races, and all backgrounds – who have been lost to the synthetic opioid crisis. More than 7,000 photos are displayed throughout the exhibit, which was enhanced last year by the addition of a new, interactive online exhibit, which is accessible at dea.gov/facesoffentanyl (opens in a new tab).
Fentanyl-related deaths have declined over the past several years, yet fentanyl remains the leading cause of death among Americans aged 18-45 years old. Last year, DEA intensified its fight against the deadly threat of synthetic opioids with the launch of its Fentanyl Free America (opens in a new tab) initiative.
DEA urges the public to remain cognizant of the extreme threat of fentanyl in our communities:
- Fentanyl is a synthetic opioid that is approximately 50 times more potent than heroin and 100 times more potent than morphine.
- Just two milligrams, the equivalent of a few grains of salt, is a potentially lethal dose.
- The Sinaloa Cartel and CJNG, both designated as Foreign Terrorist Organizations (opens in a new tab) in 2025, are pressing fentanyl into counterfeit pills that look like prescription medications – such as oxycodone, Xanax, and Percocet – as well as mixing fentanyl powder with cocaine, heroin, and methamphetamine.
- Many of the people poisoned by fentanyl had no idea they were even taking it.
- The only safe medications are ones that come from licensed and accredited medical professionals.
The DEA Museum (opens in a new tab) and Faces of Fentanyl (opens in a new tab) memorial exhibit are located at 700 Army Navy Drive, Arlington, Va., 22202. There is metered street parking around the building and a parking garage at the Fashion Centre at Pentagon City across the street.
If you would like to submit a photo of a loved one lost to fentanyl, please visit the Faces of Fentanyl web page, click on Add a Photo to the Exhibit | Faces of Fentanyl (opens in a new tab) and follow the instructions.
For more information about fentanyl and how you can join the fight, visit Fentanyl Free America | DEA.gov (opens in a new tab) and One Pill Can Kill (opens in a new tab). DEA resources are all available for public use.
Help spread awareness about the dangers of fentanyl by posting a photo on social media using the hashtag #FentanylAwarenessDay.
Our focus is to improve consistency among PDMPs, facilitate coordination between PDMPs and state and national stakeholders, increase PDMP efficiencies, measure performance and effectiveness, and promote best practices.
REQUEST PDMP TTA
Combat prescription misuse with RxCheck! Facilitate seamless data sharing among states, integrate with EHR systems, and join the nationwide PDMP movement. Developed with BJA support, RxCheck ensures secure data governance, empowering states to own and control their information.
LEARN MORE












